ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Leading Pharma, LLC

Official 2024 U.S. DOL Form 5500 summary for Leading Pharma, LLC (Leading Pharma 401(k) Plan · EIN 47-1297885 · PN 001): $5.95M net assets, 182 active participants, and $70.07 per $10,000 (70.07 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLeading Pharma, LLC
Filing IdentifierLeading Pharma 401(k) Plan · EIN 47-1297885 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$5.95M
Active Participants182
Direct Admin Fee Rate$70.07 per $10,000 (70.07 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderCommonwealth Financial Network
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI